Intermacs participation is available to all North American hospitals that implant durable mechanical circulatory support devices (MCSD) for end-stage heart failure. An annual participation fee is required. In return, each participating site receives quarterly site-specific reports comparing their data with data from other participating centers.
Contact Patricia for Intermacs participation information, patricia.potter@kirso.net.